Key Drivers
- Robust free cashflow
- High leverage
- Tight liquidity
AIAI Summary
UHS has shifted into a cash-generative, asset-heavy operator with aggressive outpatient and virtual behavioral-health growth that meaningfully ups upside if cash collections and supplemental Medicaid receipts normalize, but its elevated leverage and tight near‑term liquidity make this an event-driven trade hinging on near-term policy approvals and collection timing. Investors should wait for confirmed DC/FL/NV supplemental payments or a clear cash-collection normalization (or use the mid-$186 support as a defined, tactical entry with close stop-loss discipline) before adding exposure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Robust free cashflow
- •High leverage
- •Tight liquidity
UHS generates strong operating and free cash flow with attractive earnings multiples but is weighed down by elevated leverage and near‑term liquidity tightness amid heavy capex.
Price Behavior
Key Price Behavior Insights:
- •Sustained selling
- •Mid-$186 support
- •Layered resistance
Over last month UHS has been in a clear short-term downtrend, dropping roughly 19% from about $230 to $186 with layered resistance at $202–$207 and $229–$232 and heightened volatility after a swift multi-day decline.
Sharp multi-day drop from the $230s into the $200s late
Sentiment & News
Key News Insights:
- •revenue growth
- •Talkspace acquisition
- •governance probe
UHS delivered solid Q4 revenue and margin gains and agreed to buy Talkspace, but missed EPS expectations and faces softer admissions, rising costs and a fiduciary-duty probe.
The deal and solid underlying growth support UHS's digital expansion, but the EPS miss, cost pressure and legal scrutiny could weigh on near-term sentiment
Similar Companies in Healthcare
Other companies in the same sector with AI ratings